These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 21622563)
1. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK). Zhou H; Zhang Y; Fu Y; Chan L; Lee AS J Biol Chem; 2011 Jul; 286(29):25687-96. PubMed ID: 21622563 [TBL] [Abstract][Full Text] [Related]
2. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Fu Y; Li J; Lee AS Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086 [TBL] [Abstract][Full Text] [Related]
3. Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation. Kawiak A; Domachowska A; Jaworska A; Lojkowska E Sci Rep; 2017 Mar; 7():43781. PubMed ID: 28287102 [TBL] [Abstract][Full Text] [Related]
4. Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells. Viedma-Rodriguez R; Baiza-Gutman LA; García-Carrancá A; Moreno-Fierros L; Salamanca-Gómez F; Arenas-Aranda D Int J Oncol; 2013 Dec; 43(6):1777-86. PubMed ID: 24100375 [TBL] [Abstract][Full Text] [Related]
6. BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. Mathai JP; Germain M; Shore GC J Biol Chem; 2005 Jun; 280(25):23829-36. PubMed ID: 15809295 [TBL] [Abstract][Full Text] [Related]
7. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells. Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100 [TBL] [Abstract][Full Text] [Related]
8. The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Hur J; Chesnes J; Coser KR; Lee RS; Geck P; Isselbacher KJ; Shioda T Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2351-6. PubMed ID: 14983013 [TBL] [Abstract][Full Text] [Related]
9. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Si X; Zang R; Zhang E; Liu Y; Shi X; Zhang E; Shao L; Li A; Yang N; Han X; Pan B; Zhang Z; Sun L; Sun Y Oncotarget; 2016 Dec; 7(49):81452-81462. PubMed ID: 27845892 [TBL] [Abstract][Full Text] [Related]
10. Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway. Xie J; Tao ZH; Zhao J; Li T; Wu ZH; Zhang JF; Zhang J; Hu XC Biochem Biophys Res Commun; 2016 Jun; 474(3):612-619. PubMed ID: 27012209 [TBL] [Abstract][Full Text] [Related]
11. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Radetzki S; Köhne CH; von Haefen C; Gillissen B; Sturm I; Dörken B; Daniel PT Oncogene; 2002 Jan; 21(2):227-38. PubMed ID: 11803466 [TBL] [Abstract][Full Text] [Related]
14. Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria. Mebratu YA; Leyva-Baca I; Wathelet MG; Lacey N; Chand HS; Choi AMK; Tesfaigzi Y Nat Commun; 2017 Oct; 8(1):803. PubMed ID: 28986568 [TBL] [Abstract][Full Text] [Related]
15. The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer. Pandya V; Glubrecht D; Vos L; Hanson J; Damaraju S; Mackey J; Hugh J; Goping IS Oncotarget; 2016 May; 7(22):33272-85. PubMed ID: 27120789 [TBL] [Abstract][Full Text] [Related]
16. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells. Tseng CC; Zhang P; Lee AS Neoplasia; 2019 Aug; 21(8):837-848. PubMed ID: 31306849 [TBL] [Abstract][Full Text] [Related]
17. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Kim H; Rafiuddin-Shah M; Tu HC; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH Nat Cell Biol; 2006 Dec; 8(12):1348-58. PubMed ID: 17115033 [TBL] [Abstract][Full Text] [Related]
18. Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs. Happo L; Phipson B; Smyth GK; Strasser A; Scott CL Cell Death Dis; 2012 May; 3(5):e306. PubMed ID: 22573037 [TBL] [Abstract][Full Text] [Related]
19. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214 [TBL] [Abstract][Full Text] [Related]
20. Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK. Brosseau C; Dousset C; Touzeau C; Maïga S; Moreau P; Amiot M; Le Gouill S; Pellat-Deceunynck C Cell Death Dis; 2014 Aug; 5(8):e1389. PubMed ID: 25165875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]